Details
The NHS Genomic Medicine Service has precipitated a sharp increase in the volume and diversity of referrals for cancer-gene sequencing.
The cancer test directory informs a list of essential and investigational genes which can be targeted to maximize clinical insight.
Dr Patrick Tarpey presents an overview of large NGS panel screening from a clinical perspective, illuminating the value of permissive analysis and the necessity for a singular DSS solution to enable rapid exploration of all variant classes in a myriad of different cancer types.
Fill Out Form to Access Webinar
Your email address is never shared with third parties.
- Date & Time
- 25 Apr 2024
- Location
- Europe
- Affiliation
- Cambridge University Hospitals NHS Foundation Trust
- Presenter
- Dr Patrick Tarpey, Lead Clinical Scientist in Cancer Genetics
- Topic
- Oncology, Cancer Research